3650 results for «238»
3650 results
NSTEMI: when everything does not go as planned
21 May 2026 – From EuroPCR 2026
This session presents complex cases of NSTEMI where unexpected challenges arise during intervention. It provides a comprehensive review of complication management strategies, including coronary perforation techniques. Through detailed case analyses from diverse centers, attendees gain practical insights into troubleshooting and treatment adaptations essential for managing difficult...
Publishing in interventional cardiology: aligning authors, editors and impact
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on publishing in interventional cardiology by aligning the expectations of authors, editors, reviewers, and readers. It addresses differences in paper interpretation, common misalignments between scientific intent and editorial outcomes, and strategies to enhance clarity, relevance, and impact of scientific publications.
Precision TAVI - Seering marginal gains
21 May 2026 – From EuroPCR 2026
This session delves into precision techniques in transcatheter aortic valve implantation (TAVI), highlighting novel stepwise implantation methods for self-expanding valves, the effects of internal diameter and valve fracture on gradients post valve-in-valve TAVI, and comparative analyses of implantation-depth variability across large-size TAVI platforms. Additionally, it evaluates...
TAVI procedural complications - Part 8: aortic dissection, multiple valves procedures, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications encountered during TAVI, featuring challenging cases such as aortic dissection, multiple valve procedures including redo TAVI in patients with left ventricular assist devices, and structural failures like valve infolding and embolisation. It emphasizes strategic decision-making under critical circumstances to optimize...
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
Risk and prognosis predictors in STEMI
21 May 2026 – From EuroPCR 2026
This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction
03 Apr 2022
Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Comparison of a precision care strategy with usual testing to guide management of stable patients with suspected CAD: the PRECISE randomized trial
09 Nov 2022
Alex Sticchi provides his take on PRECISE, which was presented during AHA 2022 in Chicago.
Author
